Total: 1416

    Guideline No. 410: prevention, screening, diagnosis, and pregnancy Management for fetal neural tube defects

    J. obstet. gynaecol. Can; 43 (1), 2021
    This revised guideline is intended to provide an update on the genetic aspects, prevention, screening, diagnosis, and management of fetal neural tube defects. Target population: Women who are pregnant or may become pregnant. Neural tube defect screening should be offered to all pregnant women. For preven...

    Guideline No. 408: management of gestational trophoblastic diseases

    J. obstet. gynaecol. Can; 43 (1), 2021
    This guideline reviews the clinical evaluation and management of gestational trophoblastic diseases, including surgical and medical management of benign, premalignant, and malignant entities. The objective of this guideline is to assist health care providers in promptly diagnosing gestational trophoblast...

    Chronic mesenteric ischemia: clinical practice guidelines from the Society for Vascular Surgery

    J. vasc. surg; 73 (1), 2021
    Chronic mesenteric ischemia (CMI) results from the inability to achieve adequate postprandial intestinal blood flow, usually from atherosclerotic occlusive disease at the origins of the mesenteric vessels. Patients typically present with postprandial pain, food fear, and weight loss, although they can pr...

    Borderline ovarian tumors: french guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation

    In the Early Stages (ES) of Borderline Ovarian Tumor (BOT), if surgery without risk of tumor rupture is possible, then laparoscopy with protected extraction is recommended over laparotomy (Grade C). In case of bilateral serous ES BOT treatment with a strategy to preserve fertility and/or endocrine functi...

    WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease

    Tuberculosis (TB) is a leading cause of death from a single infectious agent, despite being largely curable and preventable. In 2019 an estimated 2.9 million of the 10 million people who fell ill with TB were not diagnosed or reported to the World Health Organization. The Political Declaration adopted by...

    Guia para el manejo terapéutico de la infección por hantavirus andes sur

    El panel priorizó la posibilidad de una reducción significativa en la mortalidad por sobre la incertidumbre en los efectos de la intervención (muy baja certeza en la evidencia), los efectos adversos del tratamiento y la carga del tratamiento en términos de utilización de recursos necesarios para imp...

    WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd ed

    Cervical cancer is a leading cause of mortality among women. In 2020, an estimated 604 000 women were diagnosed with cervical cancer worldwide and about 342 000 women died from the disease. Cervical cancer is the most commonly diagnosed cancer in 23 countries and is the leading cause of cancer death in 3...

    WHO guideline on the dairy protein content in ready-to-use therapeutic foods for treatment of uncomplicated severe acute malnutrition

    This WHO guideline is an update of the specific recommendation in the technical annex of the 2007 Joint Statement by the World Health Organization (WHO), the World Food Programme (WFP), the United Nations System Standing Committee on Nutrition (UNSSCN) and the United Nations Children’s Fund (UNICEF) on...

    WHO recommendation on prophylactic antibiotics for women undergoing caesarean section

    Direct maternal infections around the time of childbirth account for about one tenth of the global burden of maternal death. Women who develop peripartum infections are also prone to severe morbidity, long-term disabilities such as chronic pelvic pain, fallopian tube blockage and secondary infertility. M...

    WHO recommendation on routine antibiotic prophylaxis for women undergoing operative vaginal birth

    Direct maternal infections around the time of childbirth account for about one tenth of the global burden of maternal death. Women who experience peripartum infections are also prone to severe morbidity and long-term disabilities such as chronic pelvic pain, fallopian tube blockage and secondary infertil...